Clinical Trials Browser

Phase 2 × Multiple Myeloma × Pamidronate × Clear all

NCT00004088 2019-07-02

Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma

Phase 2 Completed

77 enrolled 15 charts

Multiple Myeloma, Neoplasms, Plasma Cell